Price T Rowe Associates Inc Omnicell, Inc Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Omnicell, Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 44,206 shares of OMCL stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,206
Previous 40,883
8.13%
Holding current value
$1.76 Million
Previous $1.78 Million
10.43%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding OMCL
# of Institutions
299Shares Held
45.8MCall Options Held
858KPut Options Held
75.6K-
Black Rock Inc. New York, NY8.18MShares$325 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.56MShares$221 Million0.0% of portfolio
-
State Street Corp Boston, MA2.24MShares$89.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.64MShares$65.2 Million0.02% of portfolio
-
Lazard Asset Management LLC New York, NY1.64MShares$65.2 Million0.12% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.76B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...